Advertisement
Skip to Content

Janus Henderson Global Life Sciences D JNGLX

Quantitative rating as of | See Janus Henderson Investment Hub
  • NAV / 1-Day Return 67.16  /  0.70 %
  • Total Assets 4.7 Bil
  • Adj. Expense Ratio
    0.800%
  • Expense Ratio 0.800%
  • Distribution Fee Level Below Average
  • Share Class Type No Load
  • Category Health
  • Investment Style Large Blend
  • Min. Initial Investment 2,500
  • Status Limited
  • TTM Yield 0.25%
  • Turnover 21%

Morningstar’s Analysis JNGLX

Will JNGLX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

Janus Henderson Global Life Sciences D’s management team is just average, but a solid investment process still helps this strategy retain its Morningstar Quantitative Rating of Bronze. The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Unlock our full analysis with Morningstar Investor